If we have a cheap and readily available drug that can prevent and treat the two largest causes of maternal mortality worldwide—postpartum hemorrhage and unsafe abortion—why have we not taken more advantage of it?
Reproductive rights advocates scored a couple of victories last week while the Supreme Court considers the impact of allowing patents on human genetic material.
After a short and unsurprising debate, the Indiana Senate voted 33 to 16 to pass a bill that will force all clinics that provide RU-486 for early abortions to become licensed surgical abortion facilities, regardless of whether or not they offer surgical abortions.
Both Democrats and Republicans are expressing reservations about a bill that would effectively ban medication abortion in Indiana, despite its proven safety.
The latest legal news on the contraception challenges and fight for reproductive justice in the states.
A little over a month into 2013, and one thing is absolutely certain: Anti-choice legislators aren’t going to let the damage that their war on women did to their fellow conservative politicians’ electoral prospects slow them down.
A legal challenge to the state’s restrictions on medication abortion may be close to resolution. But is that a good thing for the women in Wisconsin?
On this 40th anniversary of Roe v. Wade, we honor and celebrate US women’s legal right to abortion, and we reaffirm our commitment to ensuring that abortion is accessible to women everywhere, and that the promise of the decision is a reality for all of us.
Reproductive health and rights were once again the subject of extensive debate in state capitols in 2012. Over the course of the year, 42 states and the District of Columbia enacted 122 provisions related to reproductive health and rights. One-third of these new provisions, 43 in 19 states, sought to restrict access to abortion services.
A GOP lawmaker is looking to make Texas the latest state to restrict the use of abortion medications in a way that some experts warn could increase the drugs’ side effects while making them more expensive.